Literature DB >> 26358173

Testosterone in women--the clinical significance.

Susan R Davis1, Sarah Wahlin-Jacobsen2.   

Abstract

Testosterone is an essential hormone for women, with physiological actions mediated directly or via aromatisation to oestradiol throughout the body. Despite the crucial role of testosterone and the high circulating concentrations of this hormone relative to oestradiol in women, studies of its action and the effects of testosterone deficiency and replacement in women are scarce. The primary indication for the prescription of testosterone for women is loss of sexual desire, which causes affected women substantial concern. That no formulation has been approved for this purpose has not impeded the widespread use of testosterone by women--either off-label or as compounded therapy. Observational studies indicate that testosterone has favourable cardiovascular effects measured by surrogate outcomes; however, associations between endogenous testosterone and the risk of cardiovascular disease and total mortality, particularly in older women, are yet to be established. Adverse cardiovascular effects have not been seen in studies of transdermal testosterone therapy in women. Clinical trials suggest that exogenous testosterone enhances cognitive performance and improves musculoskeletal health in postmenopausal women. Unmet needs include the availability of approved testosterone formulations for women and studies to elucidate the contribution of testosterone to cardiovascular, cognitive, and musculoskeletal health and the risk of cancer.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26358173     DOI: 10.1016/S2213-8587(15)00284-3

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  33 in total

1.  Sexual function and sex hormones in breast cancer patients.

Authors:  Antonio Gambardella; Daniela Esposito; Giacomo Accardo; Marianna Taddeo; Antonietta Letizia; Rossella Tagliafierro; Katherine Esposito; Daniela Pasquali
Journal:  Endocrine       Date:  2017-11-14       Impact factor: 3.633

Review 2.  Sex Hormones and Cognition: Where Do We Stand?

Authors:  Satish V Khadilkar; Varsha A Patil
Journal:  J Obstet Gynaecol India       Date:  2019-04-10

3.  Preparation and In Vitro and In Vivo Evaluation of a Testosterone Film Forming Gel for the Treatment of Hypoactive Sexual Desire Disorder in Women.

Authors:  Jia Zeng; Tan-Fang Xie; Ting Huang; Fang Li; Zhi-Ping Wang; Ling-Lin Feng
Journal:  AAPS PharmSciTech       Date:  2022-02-25       Impact factor: 3.246

Review 4.  Relationships between endogenous and exogenous testosterone and cardiovascular disease in men.

Authors:  Arthi Thirumalai; Bradley D Anawalt
Journal:  Rev Endocr Metab Disord       Date:  2022-10-11       Impact factor: 9.306

Review 5.  Review of Mendelian Randomization Studies on Endometrial Cancer.

Authors:  Jian-Zeng Guo; Qi-Jun Wu; Fang-Hua Liu; Chang Gao; Ting-Ting Gong; Gang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-09       Impact factor: 6.055

6.  Androgen-dependent immune modulation in parasitic infection.

Authors:  Julie Sellau; Marie Groneberg; Hannelore Lotter
Journal:  Semin Immunopathol       Date:  2018-10-23       Impact factor: 9.623

7.  Chronic Blockade of the Androgen Receptor Abolishes Age-Dependent Increases in Blood Pressure in Female Growth-Restricted Rats.

Authors:  John Henry Dasinger; Suttira Intapad; Benjamin R Rudsenske; Gwendolyn K Davis; Ashley D Newsome; Barbara T Alexander
Journal:  Hypertension       Date:  2016-04-25       Impact factor: 10.190

Review 8.  Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications.

Authors:  Federica Piani; Isabella Melena; Kalie L Tommerdahl; Natalie Nokoff; Robert G Nelson; Meda E Pavkov; Daniël H van Raalte; David Z Cherney; Richard J Johnson; Kristen J Nadeau; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2020-12-31       Impact factor: 2.852

9.  Decreased risk of ovarian cancer associated with rs9898876 sex hormone-binding globulin gene variant.

Authors:  Sabrina Zidi; Mouna Stayoussef; Feryel K Sontini; Amel Mezlini; Besma Yacoubi-Loueslati; Wassim Y Almawi
Journal:  Mol Biol Rep       Date:  2022-03-11       Impact factor: 2.742

Review 10.  NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.

Authors:  Stefano Ballestri; Fabio Nascimbeni; Enrica Baldelli; Alessandra Marrazzo; Dante Romagnoli; Amedeo Lonardo
Journal:  Adv Ther       Date:  2017-05-19       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.